新股暗盤 | 朗詩綠色生活(1965.HK)暗盤段暴漲130%
格隆匯7月7日丨據富途證券,朗詩綠色生活(1965.HK)暗盤段現報7.47港元,較發行價3.18港元漲134.9%。公司是一家紮根長江三角洲的物業管理服務提供商,2018年至2020年收益分別為3.1億、4.32億、6億元人民幣,溢利分別為3096.1萬、3430.7萬、6556萬元人民幣,每股有形資產淨值0.71-1.02港元,2020歷史市盈率14.54-21.15倍。此次上市全球發售1億股,其中香港發售1000萬股,國際發售9000萬股,每手1000股,一手中籤率18%,香港公開發售獲8.01倍,淨籌2.586億港元,當中約56.8%擬用作戰略收購及投資。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.